1. Home
  2. BIO vs HQY Comparison

BIO vs HQY Comparison

Compare BIO & HQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$261.51

Market Cap

7.2B

Sector

Industrials

ML Signal

N/A

Logo HealthEquity Inc.

HQY

HealthEquity Inc.

N/A

Current Price

$76.76

Market Cap

7.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
BIO
HQY
Founded
1952
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Business Services
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
7.9B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
BIO
HQY
Price
$261.51
$76.76
Analyst Decision
Strong Buy
Buy
Analyst Count
4
14
Target Price
$358.50
$115.93
AVG Volume (30 Days)
296.4K
835.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
70.31
EPS
N/A
1.88
Revenue
N/A
$229,525,000.00
Revenue This Year
$2.51
$10.44
Revenue Next Year
$3.17
$7.47
P/E Ratio
$9.72
$41.80
Revenue Growth
N/A
28.68
52 Week Low
$211.43
$72.76
52 Week High
$343.12
$116.65

Technical Indicators

Market Signals
Indicator
BIO
HQY
Relative Strength Index (RSI) 33.81 44.72
Support Level $251.00 $73.82
Resistance Level $264.68 $79.75
Average True Range (ATR) 7.45 2.93
MACD -0.12 0.47
Stochastic Oscillator 2.39 28.14

Price Performance

Historical Comparison
BIO
HQY

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About HQY HealthEquity Inc.

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

Share on Social Networks: